You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GATA2 Gene Mutation

Showing 26 - 50 of 9,110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • +14 more
  • Boston, Massachusetts
  • +1 more
Dec 6, 2022

EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

Recruiting
  • EGFR Exon 20 Mutation
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

Recruiting
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • Informational Intervention
  • Survey Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation Trial in Netherlands (Risk-reducing salpingectomy with delayed

Recruiting
  • BRCA1 Gene Mutation
  • +5 more
  • Risk-reducing salpingectomy with delayed oophorectomy
  • Risk-reducing salpingo-oophorectomy
  • Tilburg, Brabant, Netherlands
  • +13 more
Nov 1, 2022

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Japan (Tazemetostat)

Completed
Has Results
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Nagoya, Aichi, Japan
  • +27 more
Nov 18, 2022

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

    Recruiting
    • Prostate Cancer
    • +2 more
    • MRI pelvis or CT imaging
    • +2 more
    • London, Sutton, Surrey, United Kingdom
      Cancer Genetics Unit, Royal Marsden Hospital
    Mar 30, 2022

    Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

    Recruiting
    • Stage I Breast Cancer
    • +7 more
    • Baltimore, Maryland
    • +6 more
    Nov 11, 2022

    BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

    Not yet recruiting
    • BRCA Mutation
    • +3 more
    • Tamoxifen 10 Mg Tablet
    • +2 more
    • Genoa, Italy
    • +3 more
    Sep 11, 2023

    HER2 Mutant NSCLC, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation Trial (ELVN-002, Fam-Trastuzumab Deruxtecan-Nxki,

    Not yet recruiting
    • HER2 Mutant Non-small Cell Lung Cancer
    • +3 more
    • (no location specified)
    Dec 6, 2022

    HER2 Gene Mutation Trial in Shanghai (Injection of IAH0968+Gemcitabine+Cisplatin, Gemcitabine+Cisplatin)

    Recruiting
    • HER2 Gene Mutation
    • Injection of IAH0968+Gemcitabine+Cisplatin
    • Gemcitabine+Cisplatin
    • Shanghai, China
      Fudan University Affiliated Zhongshan Hospital
    Aug 7, 2023

    Breast & Ovarian Cancer Risk Detection

    Recruiting
    • Adnexal Mass
    • +3 more
    • OVA360
    • Austin, Texas
      Silvana Franco
    Jul 20, 2022

    Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

    Active, not recruiting
    • Metastatic Cancer
    • HER2 Gene Mutation
    • Neratinib Maleate
    • Seoul, Korea, Republic of
      Korea university Guro hospital
    Oct 18, 2023

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    HER2 Gene Mutation Trial (Injection of IAH0968 + CAPEOX, PLACEBO+CAPEOX)

    Not yet recruiting
    • HER2 Gene Mutation
    • Injection of IAH0968 + CAPEOX
    • PLACEBO+CAPEOX
    • (no location specified)
    Jan 4, 2023

    Short Stature Trial (Increlex)

    Active, not recruiting
    • Short Stature
    • (no location specified)
    Oct 14, 2022

    Low-grade Glioma, IDH2 Gene Mutation, Recurrent Glioma Trial in Boston (Niraparib, Resection/Treatment with Niraparib)

    Recruiting
    • Low-grade Glioma
    • +4 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 19, 2022

    Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • KRAS Gene Mutation
    • Phoenix, Arizona
    • +6 more
    Nov 10, 2022

    Molecular Profiling in Prostate Cancer

    Recruiting
    • Prostate Cancer Metastatic
    • +4 more
    • Tumor molecular profiling
    • Athens, Greece
      Hellenic Cooperative Oncology Group
    Mar 15, 2022

    Prospective Research of Outcomes After Salpingo-oophorectomy

    Active, not recruiting
    • BRCA1 Gene Mutation
    • BRCA2 Gene Mutation
      • San Francisco, California
        University of California, San Francisco
      Mar 21, 2022

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

      Recruiting
      • BRCA1 Gene Mutation
      • +19 more
      • Laboratory Biomarker Analysis
      • Pembrolizumab
      • New Brunswick, New Jersey
      • +1 more
      Nov 16, 2022

      Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,

      Active, not recruiting
      • Deleterious BRCA1 Gene Mutation
      • +5 more
      • Behavioral, Psychological or Informational Intervention
      • Questionnaire Administration
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 22, 2022

      Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

      Not yet recruiting
      • Prostate Adenocarcinoma
      • +2 more
      • Biospecimen Collection
      • +6 more
      • (no location specified)
      Mar 28, 2023

      HER2-positive Breast Cancer, HER-2 Protein Overexpression, HER-2 Gene Amplification Trial in San Antonio, Fairfax (ORM-5029)

      Not yet recruiting
      • HER2-positive Breast Cancer
      • +3 more
      • San Antonio, Texas
      • +1 more
      Aug 22, 2022

      AMN, AMN Gene Mutation, X-ALD Trial in Worcester (SBT101, Imitation Procedure)

      Recruiting
      • AMN
      • +2 more
      • SBT101
      • Imitation Procedure
      • Worcester, Massachusetts
        University of Massachusetts Chan Medical School
      Jun 1, 2022